Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$991K Buy
35,303
+19,945
+130% +$531K 0.98% 21
2025
Q4
$382K Sell
15,358
-20,195
-57% -$509K 0.42% 62
2025
Q3
$901K Hold
35,553
0.85% 26
2025
Q2
$862K Buy
35,553
+7,308
+26% +$170K 0.82% 27
2025
Q1
$716K Buy
+28,245
New +$739K 0.87% 32

Other funds holding PFE

Curat Global's PFE Position: Q1 2026 in Review

Curat Global increased its Pfizer (PFE) stake by 130% in Q1 2026, buying an estimated $531K and bringing the position to 35,303 shares worth $991K. The position accounts for 0.98% of the portfolio, ranked #21.

Curat Global first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Curat Global held 35,303 shares of Pfizer worth $991K as of Q1 2026.
  • Curat Global bought 19,945 Pfizer shares in Q1 2026, an estimated $531K.
  • Pfizer made up 0.98% of Curat Global's portfolio in Q1 2026, its #21 holding.
  • Curat Global first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Curat Global's 13F filing for Q1 2026, filed 21 Apr 2026.